Letters to the Editor: If Trump really wants to help poorer Americans, he should focus on healthcare

The letter argues that President Trump’s proposal to cap credit-card interest at 10% is a diversion from the core problem of high medical costs, noting that roughly 10–12% of credit-card debt is used to cover medical expenses. It warns that eliminating Affordable Care Act tax credits will leave millions unable to afford insurance, driving more medical bills onto cards and increasing consumer credit stress—an outcome that could pressure card issuers and highlights fiscal and regulatory risks tied to healthcare affordability rather than interest-rate caps.

Analysis

Market structure: Capping card APRs at ~10% (political talk) would directly hurt credit-card specialists (COF, SYF, AXP) by compressing NIMs and forcing repricing toward secured/fee income; hospitals and health systems (UHS, THC, HCA) are indirect losers because removal of ACA credits will likely increase uninsured populations and push 10–12% of card balances into higher delinquency buckets. Competitive dynamics favor vertically integrated insurers and PBMs (UNH, CVS, HUM) that can shift care to lower-cost settings and manage payment flows; regional hospitals and smaller card issuers lose pricing power. Cross-asset: expect widened ABS spreads on credit-card receivables (+30–100bps shock scenario), modestly higher bank CDS for card-heavy issuers, and pressure on high-yield healthcare credits over 3–12 months.

Risk assessment: Tail risks include a rapid legislative cap (high-impact, low-probability) that knocks 20–30% off FY EBITDA for pure-play card lenders, or conversely a large regulatory rollback of ACA changes that stabilizes insurer pools; both could occur within 30–90 days around budget votes or court rulings. Hidden dependencies: rising medical debt is a consumer credit shock that shows up with 3–12 month lag in charge-offs and securitization performance; monitor ABS delinquency curves and 60+ day card delinquencies for early warning. Catalysts: Congressional hearings, CBO score releases, and state-level rate caps could accelerate moves.

Trade implications: Short volatility-aware positions on card issuers (3-month 25-delta put spreads on COF and AXP sized 1–2% each) to limit carry if policy noise rises; pair-short smaller hospital operators (UHS, THC) vs. long UNH/HUM (1–3% overweight) to capture relative resilience from Medicare Advantage exposure over 6–12 months. Buy protection on credit-card ABS (select 1–2% notional via tranche protection or ETF hedges) if 60+ day delinquencies rise >50bps MoM; reduce exposure to small-cap regional banks with >20% card NII exposure by 1–2% immediately.

Contrarian angles: Consensus overstates immediacy of a national 10% cap—legislative passage is low probability in next 3 months—so purely directional shorts in bank equities may be overdone; the mispricing is in single-name credit and ABS spreads if/when medical insolvency metrics rise. Historical parallel: 2010–2014 post-reform re-pricing in exchange pools showed 6–12 month lags and durable winners were integrated payers, not pure carriers. Unintended consequence: aggressive rate caps could push issuers to tighten underwriting and increase fees/limits, improving credit quality over 12–24 months and creating a recovery trade in card lenders.

Key Decisions for Investors

• Establish a hedged short: buy 3-month 25-delta put spreads on COF and AXP sized 1–2% of portfolio each (buy puts, sell lower-strike puts) to monetize policy-risk headlines while capping premium decay; re-evaluate if probability of legislative cap exceeds 30% or after major committee votes within 60 days.
• Initiate a relative-value trade: short UHS and THC (total 1–2% exposure) and overweight UNH by 1–3% for 6–12 months to capture downside in smaller hospital operators from higher uncompensated care versus resilience in Medicare-Advantaged payers.
• Buy 1–2% notional protection on credit-card ABS tranches or use ETF hedges (e.g., buy protection via short position in CFT or other card-ABS surrogate) if 60+ day card delinquencies rise >50bps MoM; scale into protection incrementally over 30–90 days.
• Reduce exposure to small/regional banks with >20% card NII (e.g., reduce FITB/KEY exposure by 1–2%) and reallocate into HUM or CVS (1–2% each) for 6–12 months as defensive healthcare and PBM exposure while ACA credit risk works through the system.